Senior insider sale
TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$52.1K
754.00 shares
What this filing means
LIN ELIZABETH YEU plans to sell 754.00 shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $52.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/18/2026ACC: 0001959173-26-002480
Director
Since Dec 2021
754.00
Shares to sell
$52.1K
Approx. market value
379.00
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/17/2026
379.00Total acquired379.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/17/2026 | Restricted Stock Vesting Compensation | 379.00 | — |
| Total | 379.00 | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
375.00
Market value
$26.0K
3/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
379.00
Market value
$26.0K
3/18/2026
Total
Units
754.00
Value
$52.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/17/2026 | 375.00 | $26.0K | — | Completed |
| Planned — Approximate Date | ||||
3/18/2026 | 379.00 | $26.0K | NASDAQ | Planned |
| Total | 754.00 | $52.1K | ||